Kobe, Japan

Hideo Ono


Average Co-Inventor Count = 3.1

ph-index = 3

Forward Citations = 30(Granted Patents)


Company Filing History:


Years Active: 1986-1990

Loading Chart...
7 patents (USPTO):Explore Patents

Title: Hideo Ono: Innovator in Antibiotic Development

Introduction

Hideo Ono is a prominent inventor based in Kobe, Japan, known for his significant contributions to the field of antibiotics. With a total of 7 patents to his name, Ono has made remarkable strides in developing therapeutic agents that combat infectious diseases and malignant tumors.

Latest Patents

One of Ono's latest patents is for Antibiotics TAN-1057, which is represented by a specific chemical formula. This novel antibiotic, produced by microorganisms belonging to the genus Flexibacter, has shown strong efficacy in inhibiting the growth of pathogenic microorganisms and malignant tumors. Therefore, it holds promise as a therapeutic agent for infectious diseases and as an antitumor agent. Another significant patent is for Antibiotic TAN-749 and its derivatives, which possess antibacterial activities against drug-resistant bacteria. This compound can be utilized as a chemotherapeutic drug for bacterial infections in mammals.

Career Highlights

Ono is currently associated with Takeda Chemical Industries, Inc., a leading pharmaceutical company. His work focuses on the development of innovative antibiotics that address critical health challenges. His research has contributed to advancements in the treatment of infections and cancer, showcasing his commitment to improving public health.

Collaborations

Ono has collaborated with notable coworkers, including Setsuo Harada and Yukimasa Nozaki. Their combined expertise has further enhanced the research and development of effective antibiotic solutions.

Conclusion

Hideo Ono's contributions to antibiotic development have made a significant impact in the medical field. His innovative work continues to pave the way for new treatments that address pressing health issues.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…